Viktor von Wyl
Viktor von Wyl
Epidemiology, Biostatistics & Prevention Institute; University of Zurich
Verified email at - Homepage
Cited by
Cited by
The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench
MC Bacon, V Von Wyl, C Alden, G Sharp, E Robison, N Hessol, S Gange, ...
Clinical and Vaccine Immunology 12 (9), 1013-1019, 2005
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …
L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ...
The Lancet infectious diseases 11 (5), 363-371, 2011
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and …
RK Gupta, A Hill, AW Sawyer, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima, ...
The Lancet infectious diseases 9 (7), 409-417, 2009
Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries
Antiretroviral Therapy Cohort Collaboration
International journal of epidemiology 38 (6), 1624-1633, 2009
Estimating the basic reproductive number from viral sequence data
T Stadler, R Kouyos, V von Wyl, S Yerly, J Böni, P Bürgisser, T Klimkait, ...
Molecular biology and evolution 29 (1), 347-357, 2012
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland
RD Kouyos, V Von Wyl, S Yerly, J Böni, P Taffé, C Shah, P Börgisser, ...
The Journal of infectious diseases 201 (10), 1488-1497, 2010
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey
S Yerly, V von Wyl, B Ledergerber, J Böni, J Schüpbach, P Bürgisser, ...
Aids 21 (16), 2223-2229, 2007
Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection
RD Kouyos, V von Wyl, S Yerly, J Böni, P Rieder, B Joos, P Taffé, C Shah, ...
Clinical infectious diseases 52 (4), 532-539, 2011
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types
V Von Wyl, S Yerly, J Böni, P Bürgisser, T Klimkait, M Battegay, H Furrer, ...
Archives of internal medicine 167 (16), 1782-1790, 2007
The disease burden of multiple sclerosis from the individual and population perspective: which symptoms matter most?
L Barin, A Salmen, G Disanto, H Babačić, P Calabrese, A Chan, ...
Multiple sclerosis and related disorders 25, 112-121, 2018
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load
S Alizon, V Von Wyl, T Stadler, RD Kouyos, S Yerly, B Hirschel, J Böni, ...
PLoS pathogens 6 (9), e1001123, 2010
Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection
M Huber, M Fischer, B Misselwitz, A Manrique, H Kuster, B Niederöst, ...
PLoS medicine 3 (11), e441, 2006
Inferring epidemic contact structure from phylogenetic trees
GE Leventhal, R Kouyos, T Stadler, V Von Wyl, S Yerly, J Böni, C Cellerai, ...
PLoS computational biology 8 (3), e1002413, 2012
The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection
S Yerly, T Junier, A Gayet-Ageron, EB El Amari, V von Wyl, HF Günthard, ...
Aids 23 (11), 1415-1423, 2009
Drivers of acceptance of COVID-19 proximity tracing apps in Switzerland: panel survey analysis
V von Wyl, M Höglinger, C Sieber, M Kaufmann, A Moser, M Serra-Burriel, ...
JMIR public health and surveillance 7 (1), e25701, 2021
Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection
A Schmid, S Gianella, V von Wyl, KJ Metzner, AU Scherrer, B Niederöst, ...
PloS one 5 (10), e13310, 2010
Early evidence of effectiveness of digital contact tracing for SARS-CoV-2 in Switzerland
M Salathé, CL Althaus, N Anderegg, D Antonioli, T Ballauz, B Edouard, ...
medRxiv, 2020.09. 07.20189274, 2020
Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
Swiss HIV Cohort Study, S Gianella, V von Wyl, M Fischer, B Niederoest, ...
Antiviral therapy 16 (4), 535-545, 2011
Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study
SM Drescher, V von Wyl, WL Yang, J Böni, S Yerly, C Shah, V Aubert, ...
Clinical Infectious Diseases 58 (2), 285-294, 2014
The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland
V von Wyl, RD Kouyos, S Yerly, J Böni, C Shah, P Bürgisser, T Klimkait, ...
Journal of infectious diseases 204 (7), 1095-1103, 2011
The system can't perform the operation now. Try again later.
Articles 1–20